Checkpoint Therapeutics
(NASDAQ:CKPT)
1.39
00
At close: May 19
1.39
00
PreMarket: 4:15PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low0.96 - 4.64
Open / Close- / -
Float / Outstanding69.9M / 91M
Vol / Avg.- / 882.6K
Mkt Cap126.5M
P/E-
50d Avg. Price1.52
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float69.9M

Checkpoint Therapeutics (NASDAQ:CKPT), Quotes and News Summary

Checkpoint Therapeutics (NASDAQ: CKPT)

Day High/Low- - -
52 Week High/Low0.96 - 4.64
Open / Close- / -
Float / Outstanding69.9M / 91M
Vol / Avg.- / 882.6K
Mkt Cap126.5M
P/E-
50d Avg. Price1.52
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float69.9M
load more
Sector: Health Care.Industry: Biotechnology
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP).

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.200
REV52.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Checkpoint Therapeutics Questions & Answers

Q
How do I buy Checkpoint Therapeutics (CKPT) stock?
A

You can purchase shares of Checkpoint Therapeutics (NASDAQ: CKPT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Checkpoint Therapeutics's (CKPT) competitors?
Q
What is the target price for Checkpoint Therapeutics (CKPT) stock?
A

The latest price target for Checkpoint Therapeutics (NASDAQ: CKPT) was reported by HC Wainwright & Co. on Tuesday, January 25, 2022. The analyst firm set a price target for 26.00 expecting CKPT to rise to within 12 months (a possible 1770.50% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Checkpoint Therapeutics (CKPT)?
A

The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $1.39 last updated May 19, 2022, 8:00 PM UTC.

Q
Does Checkpoint Therapeutics (CKPT) pay a dividend?
A

There are no upcoming dividends for Checkpoint Therapeutics.

Q
When is Checkpoint Therapeutics (NASDAQ:CKPT) reporting earnings?
A

Checkpoint Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Checkpoint Therapeutics (CKPT) going to split?
A

There is no upcoming split for Checkpoint Therapeutics.

Q
What sector and industry does Checkpoint Therapeutics (CKPT) operate in?
A

Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.